Zantac and Red cell distribution width increased - a phase IV clinical study of FDA data
Summary:
Red cell distribution width increased is reported as a side effect among people who take Zantac (ranitidine hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Benadryl, and have Relapsing-remitting multiple sclerosis.
The phase IV clinical study analyzes which people have Red cell distribution width increased when taking Zantac. It is created by eHealthMe based on reports of 432,014 people who have side effects when taking Zantac from the FDA, and is updated regularly.
What is Zantac?
Zantac has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 434,161 Zantac users. Check the latest studies of Zantac.
What is Red cell distribution width increased?
Red cell distribution width increased is found to be associated with 604 drugs and 656 conditions by eHealthMe. Check the latest studies of Red cell distribution width increased.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
432,014 people reported to have side effects when taking Zantac.
Among them, 76 people (0.02%) have Red cell distribution width increased.

Among these 76 people:
How long have people been on Zantac when they have Red cell distribution width increased? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Red cell distribution width increased when taking Zantac? *
- female: 67.65 %
- male: 32.35 %
What is the age of people who have Red cell distribution width increased when taking Zantac? *
- 0-1: 1.59 %
- 2-9: 0.0 %
- 10-19: 1.59 %
- 20-29: 7.94 %
- 30-39: 22.22 %
- 40-49: 15.87 %
- 50-59: 30.16 %
- 60+: 20.63 %
What are other drugs people take besides Zantac? *
- Benadryl: 19 people, 25.00%
- Paracetamol: 12 people, 15.79%
- Tylenol: 11 people, 14.47%
- Solu-Medrol: 10 people, 13.16%
- Lasix: 10 people, 13.16%
- Heparin: 10 people, 13.16%
- Gravol: 10 people, 13.16%
- Septra: 9 people, 11.84%
- Acetaminophen: 9 people, 11.84%
- Ditropan: 9 people, 11.84%
What are other side effects people have besides Red cell distribution width increased? *
- Haematocrit Decreased: 52 people, 68.42%
- Haemoglobin Decreased: 49 people, 64.47%
- Lymphocyte Count Decreased: 45 people, 59.21%
- Headache (pain in head): 41 people, 53.95%
- Fever: 37 people, 48.68%
- Rashes (redness): 34 people, 44.74%
- Red Blood Cell Count Decreased: 33 people, 43.42%
- Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 32 people, 42.11%
- White Blood Cell Count Decreased: 31 people, 40.79%
- Fatigue (feeling of tiredness): 31 people, 40.79%
What are the existing conditions these people have? *
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 29 people, 38.16%
- Depression: 11 people, 14.47%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 11.84%
- Headache (pain in head): 9 people, 11.84%
- Pain: 7 people, 9.21%
- Multiple Myeloma (cancer of the plasma cells): 6 people, 7.89%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 6.58%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 5 people, 6.58%
- Insomnia (sleeplessness): 5 people, 6.58%
- Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 5 people, 6.58%
* Approximation only. Some reports may have incomplete information.
Do you take Zantac and have Red cell distribution width increased?
- Check whether Red cell distribution width increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Zantac:
- Zantac (434,161 reports)
Red cell distribution width increased treatments and more:
- Red cell distribution width increased (5,525 reports)
How severe was Red cell distribution width increased and when was it recovered:
Expand to all the drugs that have ingredients of ranitidine hydrochloride:
- Red cell distribution width increased and drugs with ingredients of ranitidine hydrochloride (40 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zantac:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Red cell distribution width increased:
- Red cell distribution width increased (604 drugs)
Browse all the conditions that are associated with Red cell distribution width increased:
- Red cell distribution width increased (656 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ranitidine hydrochloride (the active ingredients of Zantac) and Zantac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Morphine Sulfate vs. Acetaminophen And Codeine Phosphate, side effect and effectiveness comparison - now
- High Blood Cholesterol and Gastritis - now
- Aplasia Pure Red Cell and drugs of ingredients of acetaminophen - a second ago
- Pulpitis Dental and drugs of ingredients of amlodipine besylate - 8 seconds ago
- Drug interactions of Lansoprazole and Coq - 10 seconds ago
- Rheumatoid Arthritis and Rehabilitation Therapy - 11 seconds ago
- Could Invega Sustenna cause Hypoglycaemia Aggravated? - 14 seconds ago
- Abilify and Sedation for Women aged 20-29 - 16 seconds ago
- Drug interactions of Morphine Sulfate and Nizatidine - 16 seconds ago
- Could Vitamin D cause Mycotic Allergy? - 17 seconds ago